Aphria missed every quarterly expectation

April 12, 2021
Aphria missed every quarterly expectation

Aphria plummets on bigger-than-expected loss and revenue miss

The international producer and distributor of medicinal and recreational cannabis, Aphria, revealed its quarterly figures.

Aphria reported a Q3 loss per share of 15 cents, more significant than what the market was expecting – 5 cents per share. During the same time last year, it had an EPS of 2 cents. Not only the earnings per share came below expectations, but also the net cannabis revenue. The consensus was C$161.5 million, but the figures came in at C$153.6 million. Year-over-year, the revenue fell almost 8%. On the other hand, the gross revenue for adult-use cannabis surged 30% to C$60 million.

The company ended the quarter with C$267.1 million in cash and cash equivalents after closing a C$120 million financing agreement with BMO.

Following the news, Aphria stock price lost more than 13%.

Sources: thestreet.com, finance.yahoo.com

This information prepared by ClickTrades.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.
This information is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation or the particular needs of any recipient.


You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.



This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of ClickTrades.com.

Recently Added

Most Affected Instruments

Aphria
arrow
aphria chart